John David Mayfield, M.D., Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Hemoptysis | 1 | 2021 | 152 | 0.670 |
Why?
|
14-3-3 Proteins | 2 | 2012 | 222 | 0.630 |
Why?
|
Multiple Sclerosis | 2 | 2024 | 3245 | 0.610 |
Why?
|
Arabidopsis | 3 | 2012 | 469 | 0.610 |
Why?
|
Aneurysm, False | 1 | 2021 | 263 | 0.600 |
Why?
|
Foramen Ovale, Patent | 1 | 2021 | 210 | 0.600 |
Why?
|
Neck Dissection | 1 | 2019 | 201 | 0.570 |
Why?
|
Carcinoma, Intraductal, Noninfiltrating | 1 | 2024 | 934 | 0.560 |
Why?
|
Carcinoma, Ductal, Breast | 1 | 2024 | 1092 | 0.560 |
Why?
|
Tongue Neoplasms | 1 | 2019 | 186 | 0.550 |
Why?
|
Pulmonary Veins | 1 | 2021 | 755 | 0.480 |
Why?
|
Chloroplasts | 1 | 2012 | 46 | 0.400 |
Why?
|
Light Signal Transduction | 1 | 2012 | 31 | 0.400 |
Why?
|
Plant Roots | 1 | 2012 | 122 | 0.380 |
Why?
|
Contrast Media | 1 | 2024 | 5336 | 0.370 |
Why?
|
Embolization, Therapeutic | 1 | 2021 | 1435 | 0.370 |
Why?
|
Lung Diseases, Interstitial | 1 | 2019 | 935 | 0.340 |
Why?
|
Magnetic Resonance Imaging | 3 | 2024 | 36840 | 0.300 |
Why?
|
Phytochrome | 1 | 2007 | 8 | 0.300 |
Why?
|
Flowers | 1 | 2007 | 30 | 0.300 |
Why?
|
Photoperiod | 1 | 2007 | 141 | 0.270 |
Why?
|
Image Interpretation, Computer-Assisted | 2 | 2024 | 3408 | 0.190 |
Why?
|
Lung | 1 | 2019 | 10090 | 0.170 |
Why?
|
Breast Neoplasms | 3 | 2024 | 21156 | 0.160 |
Why?
|
Mutagenesis, Insertional | 2 | 2012 | 662 | 0.140 |
Why?
|
Genes, erbB-2 | 1 | 2016 | 162 | 0.130 |
Why?
|
Arthroplasty | 1 | 2018 | 310 | 0.130 |
Why?
|
Breast | 1 | 2024 | 1976 | 0.120 |
Why?
|
Genes, erbB-1 | 1 | 2016 | 163 | 0.120 |
Why?
|
Mesenchymoma | 1 | 2015 | 49 | 0.120 |
Why?
|
Disease Progression | 2 | 2024 | 13655 | 0.120 |
Why?
|
Cell Adhesion Molecules | 2 | 2011 | 1615 | 0.110 |
Why?
|
Neoplasm Invasiveness | 3 | 2019 | 3637 | 0.110 |
Why?
|
Fatal Outcome | 1 | 2019 | 1840 | 0.110 |
Why?
|
Nitrate Reductase | 1 | 2012 | 11 | 0.100 |
Why?
|
Gene Fusion | 1 | 2015 | 356 | 0.100 |
Why?
|
Radiotherapy, Intensity-Modulated | 1 | 2019 | 811 | 0.100 |
Why?
|
Antigens, Neoplasm | 2 | 2011 | 2003 | 0.100 |
Why?
|
Shoulder Joint | 1 | 2018 | 749 | 0.090 |
Why?
|
Gene Expression Regulation, Plant | 1 | 2011 | 211 | 0.090 |
Why?
|
Transcription Factor AP-1 | 1 | 2011 | 321 | 0.090 |
Why?
|
Arabidopsis Proteins | 2 | 2011 | 265 | 0.090 |
Why?
|
Space Flight | 1 | 2011 | 218 | 0.080 |
Why?
|
Hypocotyl | 1 | 2007 | 7 | 0.080 |
Why?
|
Predictive Value of Tests | 1 | 2024 | 15460 | 0.070 |
Why?
|
Receptor Protein-Tyrosine Kinases | 1 | 2015 | 1628 | 0.070 |
Why?
|
DNA, Bacterial | 1 | 2012 | 1474 | 0.070 |
Why?
|
Two-Hybrid System Techniques | 1 | 2007 | 463 | 0.070 |
Why?
|
Color | 1 | 2007 | 297 | 0.070 |
Why?
|
Uterine Neoplasms | 1 | 2015 | 1422 | 0.070 |
Why?
|
Image Processing, Computer-Assisted | 1 | 2023 | 9066 | 0.060 |
Why?
|
Proto-Oncogene Proteins B-raf | 1 | 2016 | 2072 | 0.060 |
Why?
|
Protein-Tyrosine Kinases | 1 | 2015 | 2434 | 0.060 |
Why?
|
Retrospective Studies | 3 | 2024 | 81834 | 0.060 |
Why?
|
Microscopy, Confocal | 1 | 2012 | 1977 | 0.060 |
Why?
|
Light | 1 | 2012 | 1357 | 0.060 |
Why?
|
Cell Transformation, Neoplastic | 1 | 2015 | 2847 | 0.060 |
Why?
|
Biological Clocks | 1 | 2007 | 321 | 0.060 |
Why?
|
Immunohistochemistry | 1 | 2019 | 11138 | 0.060 |
Why?
|
Medicaid | 1 | 2018 | 2843 | 0.060 |
Why?
|
Neoplasm Staging | 1 | 2019 | 11249 | 0.060 |
Why?
|
Neoplasm Proteins | 1 | 2016 | 3611 | 0.060 |
Why?
|
Humans | 10 | 2024 | 768451 | 0.050 |
Why?
|
Time Factors | 1 | 2024 | 40271 | 0.050 |
Why?
|
Algorithms | 1 | 2023 | 14158 | 0.050 |
Why?
|
Female | 6 | 2024 | 396943 | 0.050 |
Why?
|
Adult | 2 | 2024 | 223542 | 0.040 |
Why?
|
Tomography, X-Ray Computed | 1 | 2023 | 20762 | 0.040 |
Why?
|
Medicare | 1 | 2018 | 6881 | 0.040 |
Why?
|
Mutation | 2 | 2016 | 30243 | 0.040 |
Why?
|
Aged | 2 | 2024 | 171520 | 0.040 |
Why?
|
Tumor Suppressor Protein p53 | 1 | 2009 | 2964 | 0.040 |
Why?
|
Risk Assessment | 1 | 2019 | 24311 | 0.040 |
Why?
|
Treatment Outcome | 2 | 2021 | 65409 | 0.030 |
Why?
|
Base Pairing | 1 | 2016 | 139 | 0.030 |
Why?
|
Preoperative Period | 1 | 2018 | 564 | 0.030 |
Why?
|
Aged, 80 and over | 1 | 2021 | 59680 | 0.030 |
Why?
|
Protein Conformation | 2 | 2016 | 3973 | 0.030 |
Why?
|
Male | 3 | 2024 | 364781 | 0.030 |
Why?
|
Dimerization | 1 | 2016 | 888 | 0.030 |
Why?
|
Middle Aged | 3 | 2024 | 223418 | 0.030 |
Why?
|
Postoperative Period | 1 | 2018 | 1833 | 0.030 |
Why?
|
Protein Structure, Secondary | 1 | 2016 | 1223 | 0.030 |
Why?
|
Conserved Sequence | 1 | 2016 | 1164 | 0.030 |
Why?
|
Protein Interaction Mapping | 1 | 2016 | 616 | 0.030 |
Why?
|
Sequence Homology, Amino Acid | 1 | 2016 | 2751 | 0.020 |
Why?
|
Sequence Alignment | 1 | 2016 | 2184 | 0.020 |
Why?
|
Genome, Plant | 1 | 2011 | 84 | 0.020 |
Why?
|
Amino Acid Substitution | 1 | 2016 | 1744 | 0.020 |
Why?
|
Range of Motion, Articular | 1 | 2018 | 1599 | 0.020 |
Why?
|
Proto-Oncogene Proteins c-jun | 1 | 2011 | 287 | 0.020 |
Why?
|
Weightlessness | 1 | 2011 | 102 | 0.020 |
Why?
|
Structure-Activity Relationship | 1 | 2016 | 3073 | 0.020 |
Why?
|
DNA-Binding Proteins | 1 | 2007 | 9623 | 0.020 |
Why?
|
Molecular Sequence Data | 2 | 2016 | 17647 | 0.020 |
Why?
|
Enzyme Activation | 1 | 2016 | 3594 | 0.020 |
Why?
|
Phenotype | 1 | 2007 | 16712 | 0.020 |
Why?
|
Social Class | 1 | 2018 | 2000 | 0.020 |
Why?
|
Cell Wall | 1 | 2011 | 420 | 0.020 |
Why?
|
Signal Transduction | 2 | 2011 | 23638 | 0.020 |
Why?
|
HCT116 Cells | 1 | 2009 | 406 | 0.020 |
Why?
|
Transcription Factors | 1 | 2007 | 12174 | 0.020 |
Why?
|
Pain Measurement | 1 | 2018 | 3577 | 0.020 |
Why?
|
Reoperation | 1 | 2018 | 4342 | 0.020 |
Why?
|
Neoplasms | 1 | 2016 | 22386 | 0.020 |
Why?
|
Chromatin Immunoprecipitation | 1 | 2009 | 856 | 0.020 |
Why?
|
Models, Molecular | 1 | 2016 | 5443 | 0.020 |
Why?
|
Receptor, erbB-2 | 1 | 2016 | 2586 | 0.020 |
Why?
|
Mice, Nude | 1 | 2011 | 3635 | 0.020 |
Why?
|
MAP Kinase Signaling System | 1 | 2011 | 1489 | 0.010 |
Why?
|
Amino Acid Sequence | 1 | 2016 | 13452 | 0.010 |
Why?
|
Gene Expression Regulation, Neoplastic | 2 | 2011 | 8635 | 0.010 |
Why?
|
Cell Line, Tumor | 2 | 2011 | 17149 | 0.010 |
Why?
|
Xenograft Model Antitumor Assays | 1 | 2011 | 3619 | 0.010 |
Why?
|
Drug Resistance, Neoplasm | 1 | 2016 | 5342 | 0.010 |
Why?
|
Phosphorylation | 1 | 2011 | 8332 | 0.010 |
Why?
|
Binding Sites | 1 | 2009 | 6030 | 0.010 |
Why?
|
Protein Kinase Inhibitors | 1 | 2016 | 5709 | 0.010 |
Why?
|
Genomics | 1 | 2015 | 5909 | 0.010 |
Why?
|
Gene Expression | 1 | 2011 | 7605 | 0.010 |
Why?
|
Base Sequence | 1 | 2009 | 12428 | 0.010 |
Why?
|
Follow-Up Studies | 1 | 2018 | 39430 | 0.010 |
Why?
|
Transcription, Genetic | 1 | 2009 | 7599 | 0.010 |
Why?
|
Antineoplastic Agents | 1 | 2016 | 13708 | 0.010 |
Why?
|
United States | 1 | 2018 | 73121 | 0.010 |
Why?
|
Mice | 1 | 2011 | 82045 | 0.000 |
Why?
|
Animals | 1 | 2011 | 169418 | 0.000 |
Why?
|